These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34672719)

  • 1. Comprehensive analysis of R-groups in medicinal chemistry.
    Bajorath J
    Future Med Chem; 2022 Jan; 14(1):5-7. PubMed ID: 34672719
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic mapping of R-group space enables the generation of an R-group replacement system for medicinal chemistry.
    Takeuchi K; Kunimoto R; Bajorath J
    Eur J Med Chem; 2021 Dec; 225():113771. PubMed ID: 34403977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Into the Fray! A Beginner's Guide to Medicinal Chemistry.
    Veale CGL
    ChemMedChem; 2021 Apr; 16(8):1199-1225. PubMed ID: 33591595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
    Dimova D; Heikamp K; Stumpfe D; Bajorath J
    J Med Chem; 2013 Apr; 56(8):3339-45. PubMed ID: 23527828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in exploring activity cliffs.
    Stumpfe D; Hu H; Bajorath J
    J Comput Aided Mol Des; 2020 Sep; 34(9):929-942. PubMed ID: 32367387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Assessment of Substituents on the Basis of Analogue Series.
    Takeuchi K; Kunimoto R; Bajorath J
    J Med Chem; 2020 Dec; 63(23):15013-15020. PubMed ID: 33253557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
    Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
    Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the utility of molecular scaffolds for medicinal and computational chemistry.
    Bajorath J
    Future Med Chem; 2018 Jul; 10(14):1645-1648. PubMed ID: 29957045
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicinal chemistry in drug discovery in big pharma: past, present and future.
    Campbell IB; Macdonald SJF; Procopiou PA
    Drug Discov Today; 2018 Feb; 23(2):219-234. PubMed ID: 29031621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random molecular fragment methods in computational medicinal chemistry.
    Lounkine E; Batista J; Bajorath J
    Curr Med Chem; 2008; 15(21):2108-21. PubMed ID: 18781938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal chemistry: Exploring the third dimension.
    Kingwell K
    Nat Rev Drug Discov; 2009 Dec; 8(12):931. PubMed ID: 19967797
    [No Abstract]   [Full Text] [Related]  

  • 17. MB-Isoster: A software for bioisosterism simulation.
    Elias TC; de Oliveira HCB; da Silveira NJF
    J Comput Chem; 2018 Nov; 39(29):2481-2487. PubMed ID: 30318630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational prediction of drug-target interactions in medicinal chemistry.
    González-Díaz H
    Curr Top Med Chem; 2013; 13(14):1619-21. PubMed ID: 23889056
    [No Abstract]   [Full Text] [Related]  

  • 19. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual exploration of structure-activity relationship using maximum common framework.
    Cho SJ; Sun Y
    J Comput Aided Mol Des; 2008 Aug; 22(8):571-8. PubMed ID: 18338222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.